In this handout photo taken on Thursday, Aug. 6, 2020, and provided by Russian Direct Investment Fund, a new vaccine is on display at the Nikolai Gamaleya National Center of Epidemiology and Microbiology in Moscow, Russia. Russia on Tuesday, Aug. 11 became the first country to approve a coronavirus vaccine for use in tens of thousands of its citizens despite international skepticism about injections that have not completed clinical trials and were studied in only dozens of people for less than two months. (Alexander Zemlianichenko Jr/ Russian Direct Investment Fund via AP)
|
|
20224525667406
|
|
|
August 06, 2020 01:55:11 PM
|
|
|
August 11, 2020 02:38:46 PM
|
|
|
Alexander Zemlianichenko Jr
|
|
|
Russian Direct Investment Fund
|
|
|
ASSOCIATED PRESS
|
|
|
AP PROVIDES ACCESS TO THIS PUBLICLY DISTRIBUTED HANDOUT PHOTO PROVIDED BY THE Russian Direct Investment Fund ; MANDATORY CREDIT.
|
|
|
4663 x 3116 5.53 MB
|
|
|
2019-2020 Coronavirus pandemic, Coronavirus, Infectious diseases, Diseases and conditions, Health, Coronavirus, Lung disease, Immunizations, Public health, Disease outbreaks, General news, Disease outbreaks
|
|
|
COVID-19, coronavirus
|
|
|
Moscow, RUSSIAN FEDERATION
|
|
|
XAZ167
|
|
|
This content is intended for editorial use only. For other uses, additional clearances may be required.
|
